Page last updated: 2024-10-22

aminoglutethimide and Empty Sella Syndrome

aminoglutethimide has been researched along with Empty Sella Syndrome in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Empty Sella Syndrome: A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: (1) primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; (2) secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schramm, J1
Wüster, C1

Other Studies

1 other study available for aminoglutethimide and Empty Sella Syndrome

ArticleYear
[Inhibited depressive syndrome in a patient with Cushing disease and anterior hypophysial insufficiency].
    Der Nervenarzt, 1991, Volume: 62, Issue:3

    Topics: Aminoglutethimide; Cushing Syndrome; Depressive Disorder; Empty Sella Syndrome; Female; Humans; Hydr

1991